The purpose of this study was to examine whether morphologic abnormalities in human respiratory muscles are related to increased airway obstruction. 43 patients who were undergoing thoracotomy for suspected neoplasm had biopsies taken from one or more of the following muscles: external intercostal (EXT), internal intercostal (INT), diaphragm (DIA), latissimus dorsi (LAT), and quadriceps femoris (LEG). Mean FEV1/FVC was 65% of predicted (range 43–90%). 21 of the 43 patients had a malignancy. Atrophy of type I fibers was found in 27% of respiratory and 11 % of nonrespiratory muscles. Type II fiber atrophy was more common, being found in 58% of all muscles studied. The degree of type II fiber atrophy correlated significantly with the amount of weight loss, but not with age or the presence of malignancy. A unique and significant relationship was found between type II fiber atrophy in the INT (an expiratory muscle) and all measured indices of airway obstruction. This relationship did not exist in the DIA, EXT, or LAT, ordinarily considered muscles of inspiration. The percentage of type I and type II fibers bore no relationship to indices of airway obstruction. Depletion of muscle metabolites was common to all muscles and could not be related to airway obstruction or fiber atrophy. These data suggest that fiber atrophy and metabolite depletion occur commonly in both respiratory and nonrespiratory muscles in patients with stable obstructive lung disease. These changes probably reflect a generalized disease process and may predispose to muscle fatigue. Whether or not airway obstruction produces fiber atrophy in expiratory muscles requires further investigation.

Keywords:
Chronic obstructive lung disease, Muscle fiber atrophy, Fatigue, Muscle fuels
This content is only available via PDF.
© 1983 S. Karger AG, Basel
1983
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.